Cargando…
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
PURPOSE: Comprehensive genomic profiling identifying actionable molecular alterations aims to enable personalized treatment for cancer patients. The purpose of this analysis was to retrospectively assess the impact of personalized recommendations made by a multidisciplinary tumor board (MTB) on the...
Autores principales: | Sultova, Elena, Westphalen, C. Benedikt, Jung, Andreas, Kumbrink, Joerg, Kirchner, Thomas, Mayr, Doris, Rudelius, Martina, Ormanns, Steffen, Heinemann, Volker, Metzeler, Klaus H., Greif, Philipp A., Burges, Alexander, Trillsch, Fabian, Mahner, Sven, Harbeck, Nadia, Wuerstlein, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053190/ https://www.ncbi.nlm.nih.gov/pubmed/33277683 http://dx.doi.org/10.1007/s00404-020-05881-z |
Ejemplares similares
-
Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
por: Sultova, Elena, et al.
Publicado: (2021) -
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany
por: Kaltofen, Till, et al.
Publicado: (2021) -
Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience
por: Berclaz, Luc M., et al.
Publicado: (2023) -
Cosmic Ray test stand at the LMU Munich
por: Hessey, N P, et al.
Publicado: (1998) -
Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board
por: Heinrich, Kathrin, et al.
Publicado: (2022)